Welcome to Aranda Pharma’s investor event!
18:00 Introductions, moderator Milla Koistinaho
18:05 Company presentation, CEO Anu Muona
18:15 Q&A
18:45 The end
The event will be recorded, and the recording will be sent to attendees afterwards.
Check out all Aranda Pharma’s investor materials at the Invesdor platform: https://invest.invesdor.com/en/pitches/1102
Important notice: All investments carry a risk of losing capital. Invest responsibly and always familiarize yourself with the whole investment material before making an investment decision.
Participants
Anu Muona
Founder and CEO
As one of the founders of Aranda Pharma Anu Muona has been involved in the ADA-308 project since its inception. Anu holds a PhD in Molecular Biology and has made an academic career in collagen research and neurodegenerative diseases. Anu has more than 10 years of experience in preclinical drug development in small molecules for various target indications.
Mikko Mannerkoski
Chairman of the Board and advisor / CFO, Rappta Therapeutics Ltd
Mikko Mannerkoski has more than 20 years of experience in investment banking and growth companies. For the past 10 years Mikko has been involved in biotech companies in both Finland and the US as a founder, shareholder, and executive. Mikko has vast experience in creating and executing value-creating strategies for growth companies in the life science sector. Mikko holds a MSc in technology from the Helsinki University of Technology and an MBA in finance from the Helsinki School of Economics.
Moderator
Milla Koistinaho
Founder, Board member and advisor / COO, Helsinki Innovation Services
Milla Koistinaho is a serial entrepreneur who has co-founded three biotech companies in Finland including Aranda Pharma. Milla has more than 20 years of experience in preclinical drug development and commercialization of life science invention via licensing or IP sales. Milla holds a PhD and is an adjunct professor in Neurobiology and has made an academic career in research of neurodegenerative diseases. Milla is well connected in the life science sector both nationally and internationally.